CARRIE WORSHAM: Open Payments
NPI 1003291683 · HORN LAKE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,289 in 97 payments from 17 companies in 2025. Trend: 2023 $2,954 · 2024 $2,522 · 2025 $2,289
Food & beverage: $2,289
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 25 | $511 |
| Novo Nordisk Inc | 10 | $282 |
| Corcept Therapeutics | 7 | $271 |
| ABBVIE INC. | 15 | $248 |
| Lilly USA, LLC | 10 | $235 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $212 |
| Abbott Laboratories | 3 | $143 |
| GlaxoSmithKline, LLC. | 5 | $92 |
| Sumitomo Pharma America, Inc. | 3 | $63 |
| SHIELD THERAPEUTICS INC | 2 | $43 |
Products named: FARXIGA, Korlym, JARDIANCE, AIRSUPRA, FREESTYLE LIBRE 3, LINZESS, Wegovy, ZEPBOUND.
Industry payments across MS — which companies pay providers there.
